Portrait de Guillaume Dumas

Guillaume Dumas

Membre académique associé
Professeur agrégé, Université de Montréal, Département de psychiatrie et d’addictologie
Professeur adjoint, McGill University, Département de psychiatrie
Sujets de recherche
Apprentissage automatique médical
Apprentissage par renforcement
Apprentissage profond
Biologie computationnelle
Neurosciences computationnelles
Systèmes dynamiques
Théorie de l'apprentissage automatique
Site web
Google Scholar
LinkedIn
X

Biographie

Guillaume Dumas est professeur agrégé de psychiatrie computationnelle à la Faculté de médecine de l'Université de Montréal et chercheur principal du laboratoire de psychiatrie de précision et de physiologie sociale du Centre de recherche du CHU Sainte-Justine. Il est titulaire de la chaire IVADO IA en santé mentale et chercheur-boursier junior 1 du Fonds de recherche du Québec - Santé (FRQS) dans le domaine de l’ IA en santé et de la santé numérique. En 2023, il a été retenu dans le cadre du Programme des chercheurs mondiaux CIFAR-Azrieli pour le programme de recherche Cerveau, esprit et conscience. Il a également été nommé parmi les Futurs leaders canadiens de la recherche sur le cerveau par la Fondation Brain Canada.

Il a auparavant été chercheur permanent en neurosciences et en biologie computationnelle à l'Institut Pasteur (Paris, France), ainsi que chercheur postdoctoral au Center for Complex Systems and Brain Sciences à l’Université Florida Atlantic (FAU), aux États-Unis. Il est titulaire d'un diplôme d'ingénieur en ingénierie avancée et informatique (École centrale Paris), de deux masters (physique théorique, Université Paris-Saclay; sciences cognitives, ENS/EHESS/Paris 5) et d'un doctorat en neurosciences cognitives (Sorbonne Université).

Ses recherches visent à combiner l’intelligence artificielle, les neurosciences cognitives et la médecine numérique à travers un programme interdisciplinaire suivant deux axes principaux :

- L’intelligence artificielle en santé mentale, par la création de nouveaux algorithmes pour étudier le développement de l'architecture cognitive humaine et pour fournir une médecine personnalisée en neuropsychiatrie grâce à des données allant du génome à celles des téléphones intelligents;

- Les neurosciences sociales en intelligence artificielle, par la traduction de la recherche fondamentale sur le cerveau et le formalisme des systèmes dynamiques en des modèles hybrides neurocomputationnels et d’apprentissage automatique (NeuroML) et de nouvelles architectures présentant des capacités d'apprentissage social (NeuroIA Sociale et IHM).

Étudiants actuels

Saskia Helbling
Postdoctorat - UdeM
Site web
Github
Google Scholar
Nadine Mohamed
Maîtrise recherche - UdeM
Rémy Ramadour
Visiteur de recherche indépendant - CHU Sainte Justine / Université de Montréal
Site web
Github
Mahta Ramezanian
Maîtrise recherche - UdeM
Superviseur⋅e principal⋅e :
Irina Rish
Pascal Tikeng Notsawo
Doctorat - UdeM
Superviseur⋅e principal⋅e :
Guillaume Rabusseau
Site web
Github
Google Scholar

Publications

Neurobiological Correlates of Change in Adaptive Behavior in Autism.
Charlotte M. Pretzsch
Tim Schäfer
Michael V. Lombardo
Varun Warrier
Caroline Mann
Anke Bletsch
Chris H. Chatham
Dorothea L. Floris
Julian Tillmann
Afsheen Yousaf
Emily J. H. Jones
Tony Charman
Sara Ambrosino
Thomas Bourgeron
Guillaume Dumas
Eva Loth
Beth Oakley
Jan K. Buitelaar
Freddy Cliquet
Claire Leblond … (voir 7 de plus)
Simon Baron-Cohen
Christian Beckmann
Tobias Banaschewski
Sarah Durston
Christine M. Freitag
Declan Murphy
Christine Ecker
2022-03-24
American Journal of Psychiatry (publié)
doi.org
WOODS: Benchmarks for Out-of-Distribution Generalization in Time Series Tasks
Jean-christophe Gagnon-audet
Kartik Ahuja
Mohammad Javad Darvishi Bayazi
Guillaume Dumas
Irina Rish
2022-03-17
ArXiv (prépublication)
doi.org
arxiv.org
Interindividual Differences in Cortical Thickness and Their Genomic Underpinnings in Autism Spectrum Disorder.
Christine Ecker
Charlotte M. Pretzsch
Anke Bletsch
Caroline Mann
Tim Schaefer
Sara Ambrosino
Julian Tillmann
Afsheen Yousaf
Andreas Chiocchetti
Michael V. Lombardo
Varun Warrier
Nico Bast
Carolin Moessnang
Sarah Baumeister
Flavio Dell’Acqua
Dorothea L. Floris
Mariam Zabihi
Andre Marquand
Freddy Cliquet
Claire Leblond … (voir 19 de plus)
Clara A. Moreau
Nick Puts
Tobias Banaschewski
Emily J. H. Jones
Luke Mason
Sven Bölte
Andreas Meyer-Lindenberg
Antonio Persico
Sarah Durston
Simon Baron-Cohen
Will Spooren
Eva Loth
Christine M. Freitag
Tony Charman
Guillaume Dumas
Thomas Bourgeron
Christian Beckmann
Jan K. Buitelaar
Declan Murphy
2022-02-28
American Journal of Psychiatry (publié)
doi.org
Multilevel development of cognitive abilities in an artificial neural network
Konstantin Volzhenin
Jean-Pierre Changeux
Guillaume Dumas
Multiple biological mechanisms support the unique ability of the brain to develop complex cognitive abilities. Nevertheless, it remains uncl… (voir plus)ear which mechanisms are necessary and sufficient. We propose a neurocomputational model of the developing brain spanning sensorimotor, cognitive, and conscious levels. The model solves three tasks of increasing complexity: from visual recognition to cognitive manipulation and maintenance of conscious percepts. Results highlight two fundamental mechanisms for the multilevel development of cognitive abilities in biological neural networks: 1) synaptic epigenesis, with Hebbian learning at the local scale and reinforcement learning at the global scale; and 2) self-organized dynamics, through spontaneous activity and balanced excitatory/inhibitory ratio of neurons. We emphasize how these core features of human intelligence could guide future development in artificial intelligence.
2022-01-24
bioRxiv (prépublication)
doi.org
Analysis of the Human Pineal Proteome by Mass Spectrometry
Mariette Matondo
Guillaume Dumas
Erik Maronde
2021-12-31
Methods in molecular biology (publié)
doi.org
Generative Models of Brain Dynamics -- A review
Mahta Ramezanian Panahi
Germán Abrevaya
Jean-christophe Gagnon-audet
Vikram Voleti
Irina Rish
Guillaume Dumas
The principled design and discovery of biologically- and physically-informed models of neuronal dynamics has been advancing since the mid-tw… (voir plus)entieth century. Recent developments in artificial intelligence (AI) have accelerated this progress. This review article gives a high-level overview of the approaches across different scales of organization and levels of abstraction. The studies covered in this paper include fundamental models in computational neuroscience, nonlinear dynamics, data-driven methods, as well as emergent practices. While not all of these models span the intersection of neuroscience, AI, and system dynamics, all of them do or can work in tandem as generative models, which, as we argue, provide superior properties for the analysis of neuroscientific data. We discuss the limitations and unique dynamical traits of brain data and the complementary need for hypothesis- and data-driven modeling. By way of conclusion, we present several hybrid generative models from recent literature in scientific machine learning, which can be efficiently deployed to yield interpretable models of neural dynamics.
2021-12-21
ArXiv (prépublication)
arxiv.org
arxiv.org
Preference for biological motion is reduced in ASD: implications for clinical trials and the search for biomarkers
Luke Mason
F. Shic
T. Falck-Ytter
Bhismadev Chakrabarti
Tony Charman
Eva Loth
Julian Tillmann
Tobias Banaschewski
Simon Baron-Cohen
Sven Bölte
J. Buitelaar
Sarah Durston
Bob Oranje
Antonio Persico
C. Beckmann
Thomas Bougeron
Flavio Dell’Acqua
Christine Ecker
Carolin Moessnang
D. Murphy … (voir 49 de plus)
M. H. Johnson
Emily J. H. Jones
Jumana Sara Sarah Carsten Michael Daniel Claudia Yvette Chris Ineke Daisy Guillaume Jessica Vincent Pilar David Lindsay Joerg Rosemary Meng-Chuan Xavier Liogier Michael V. David J. René Andre Maarten Andreas Nico Bethany Laurence Marianne Gahan Barbara Amber Jessica Roberto Antonia San José Emily Will Roberto Heike Jack Steve C. R. Caroline Marcel P. Ahmad
Jumana Sara Sarah Carsten Michael Daniel Claudia Yvette C Ahmad Ambrosino Baumeister Bours Brammer Brandeis
Jumana Ahmad
Sara Ambrosino
Sarah Baumeister
Carsten Bours
Michael Brammer
Daniel Brandeis
Claudia Brogna
Yvette de Bruijn
Christopher H. Chatham
Ineke Cornelissen
Daisy Crawley
Guillaume Dumas
Jessica Faulkner
Vincent Frouin
Pilar Garcés
David Goyard
Lindsay Ham
Joerg F. Hipp
Rosemary Holt
Meng-Chuan Lai
Xavier Liogier D’ardhuy
Michael V. Lombardo
David J. Lythgoe
René Mandl
Andre Marquand
Maarten Mennes
Andreas Meyer-Lindenberg
Nico Bast
Beth Oakley
Larry O’Dwyer
Marianne Oldehinkel
Gahan Pandina
Barbara Ruggeri
Amber N. V. Ruigrok
Jessica Sabet
Roberto Sacco
Antonia San José Cáceres
Emily Simonoff
Will Spooren
Roberto Toro
Heike Tost
Jack Waldman
Steve C. R. Williams
Caroline Wooldridge
Marcel P. Zwiers
2021-12-14
Molecular Autism (publié)
doi.org
Early Transcriptional Changes in Rabies Virus-Infected Neurons and Their Impact on Neuronal Functions
Seonhee Kim
Florence Larrous
Hugo Varet
Rachel Legendre
Lena Feige
Guillaume Dumas
Rebecca Matsas
Georgia Kouroupi
Regis Grailhe
Hervé Bourhy
Rabies is a zoonotic disease caused by rabies virus (RABV). As rabies advances, patients develop a variety of severe neurological symptoms t… (voir plus)hat inevitably lead to coma and death. Unlike other neurotropic viruses that can induce symptoms of a similar range, RABV-infected post-mortem brains do not show significant signs of inflammation nor the structural damages on neurons. This suggests that the observed neurological symptoms possibly originate from dysfunctions of neurons. However, many aspects of neuronal dysfunctions in the context of RABV infection are only partially understood, and therefore require further investigation. In this study, we used differentiated neurons to characterize the RABV-induced transcriptomic changes at the early time-points of infection. We found that the genes modulated in response to the infection are particularly involved in cell cycle, gene expression, immune response, and neuronal function-associated processes. Comparing a wild-type RABV to a mutant virus harboring altered matrix proteins, we found that the RABV matrix protein plays an important role in the early down-regulation of host genes, of which a significant number is involved in neuronal functions. The kinetics of differentially expressed genes (DEGs) are also different between the wild type and mutant virus datasets. The number of modulated genes remained constant upon wild-type RABV infection up to 24 h post-infection, but dramatically increased in the mutant condition. This result suggests that the intact viral matrix protein is important to control the size of host gene modulation. We then examined the signaling pathways previously studied in relation to the innate immune responses against RABV, and found that these pathways contribute to the changes in neuronal function-associated processes. We further examined a set of regulated genes that could impact neuronal functions collectively, and demonstrated in calcium imaging that indeed the spontaneous activity of neurons is influenced by RABV infection. Overall, our findings suggest that neuronal function-associated genes are modulated by RABV early on, potentially through the viral matrix protein-interacting signaling molecules and their downstream pathways.
2021-12-12
Frontiers in Microbiology (publié)
doi.org
Maternal chemosignals enhance infant-adult brain-to-brain synchrony
Yaara Endevelt-Shapira
Amir Djalovski
Guillaume Dumas
Ruth Feldman
2021-12-09
Science Advances (publié)
doi.org
Hypo- and hyper- sensory processing heterogeneity in Autism Spectrum Disorder
Aline Lefebvre
Julian Tillmann
Freddy Cliquet
Frederique Amsellem
Anna Maruani
Claire Leblond
Anita Beggiato
David Germanaud
Anouck Amestoy
Myriam Ly‐Le Moal
Daniel Umbricht
Christopher Chattam
Lorraine Murtagh
Manuel Bouvard
Marion Leboyer
Tony Charman
Thomas Bourgeron
Richard Delorme
Guillaume Dumas
Background. Sensory processing atypicalities are part of the core symptoms of autism spectrum disorder (ASD) and could result from an excita… (voir plus)tion/inhibition imbalance. Yet, the convergence level of phenotypic sensory processing atypicalities with genetic alterations in GABA-ergic and glutamatergic pathways remains poorly understood. This study aimed to characterize the distribution of hypo/hyper-sensory profile among individuals with ASD and investigate the role of deleterious mutations in GABAergic and glutamatergic pathways related genes in sensory processing atypicalities. Method. From the Short Sensory Profile (SSP) questionnaire, we defined and explored a score – the differential Short Sensory Profile (dSSP) - as a normalized and centralized hypo/hypersensitivity ratio for 1136 participants (533 with ASD, 210 first-degree relatives, and 267 controls) from two independent study samples (PARIS and LEAP). We also performed an unsupervised item-based clustering analysis on SSP items scores to validate this new categorization in terms of hypo and hyper sensitivity. We then explored the link between the dSSP score and the burden of deleterious mutations in a subset of individuals for which whole-genome sequencing data were available. Results. We observed a mean dSSP score difference between ASD and controls, driven mostly by a high dSSP score variability among groups (PARIS: p0.0001, η2 = 0.0001, LEAP: p0.0001, Cohen’s d=3.67). First-degree relatives were with an intermediate distribution variability prof
2021-11-29
(publié)
doi.org
The meaning of significant mean group differences for biomarker discovery
Eva Loth
Jumana Ahmad
Chris Chatham
Beatriz López
Ben Carter
Daisy Crawley
Bethany Oakley
Hannah Hayward
Jennifer Cooke
Antonia San José Cáceres
Danilo Bzdok
Emily Jones
Tony Charman
Christian Beckmann
Thomas Bourgeron
Roberto Toro
Jan Buitelaar
Declan Murphy
Guillaume Dumas
Over the past decade, biomarker discovery has become a key goal in psychiatry to aid in the more reliable diagnosis and prognosis of heterog… (voir plus)eneous psychiatric conditions and the development of tailored therapies. Nevertheless, the prevailing statistical approach is still the mean group comparison between “cases” and “controls,” which tends to ignore within-group variability. In this educational article, we used empirical data simulations to investigate how effect size, sample size, and the shape of distributions impact the interpretation of mean group differences for biomarker discovery. We then applied these statistical criteria to evaluate biomarker discovery in one area of psychiatric research—autism research. Across the most influential areas of autism research, effect size estimates ranged from small (d = 0.21, anatomical structure) to medium (d = 0.36 electrophysiology, d = 0.5, eye-tracking) to large (d = 1.1 theory of mind). We show that in normal distributions, this translates to approximately 45% to 63% of cases performing within 1 standard deviation (SD) of the typical range, i.e., they do not have a deficit/atypicality in a statistical sense. For a measure to have diagnostic utility as defined by 80% sensitivity and 80% specificity, Cohen’s d of 1.66 is required, with still 40% of cases falling within 1 SD. However, in both normal and nonnormal distributions, 1 (skewness) or 2 (platykurtic, bimodal) biologically plausible subgroups may exist despite small or even nonsignificant mean group differences. This conclusion drastically contrasts the way mean group differences are frequently reported. Over 95% of studies omitted the “on average” when summarising their findings in their abstracts (“autistic people have deficits in X”), which can be misleading as it implies that the group-level difference applies to all individuals in that group. We outline practical approaches and steps for researchers to explore mean group comparisons for the discovery of stratification biomarkers.
2021-10-31
PLoS Computational Biology (publié)
doi.org
Inter-Brain Synchronization: From Neurobehavioral Correlation to Causal Explanation
Guillaume Dumas
2021-09-30
International Journal of Psychophysiology (publié)
doi.org